BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Deals

  Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB

  Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.

  November 29, 2023

   · 

  12 min read
• Policy

  Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China

  Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals communicated that the National Medical Products Administration accepted the new drug application for Hexvix® in China.

  November 29, 2023

   · 

  5 min read
• Italfarmaco Group Announces New PDUFA Date for Givinostat DMD NDA

  Italfarmaco Group announced that the U.S. Food and Drug Administration has extended the review process of the New Drug Application for Givinostat, the company’s proprietary histone deacetylase inhibitor for the treatment of Duchenne Muscular Dystrophy.

  November 29, 2023

   · 

  2 min read